| |
| |
|
| Insider
Information: |
Curnutte John T |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
130,934 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,832,858 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
130,934 |
|
|
| Total
Value |
$1,832,858 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Portola Pharmaceuticals Inc |
PTLA |
EVP R&D |
2019-05-20 |
101,656 |
2014-06-16 |
0 |
Premium* |
|
|
Pliant Therapeutics, Inc. |
PLRX |
Director |
2020-06-02 |
29,278 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLRX |
Pliant Therapeutics, Inc. |
Director |
– • – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
29,278 |
|
- |
|
| PTLA |
Portola Pharmaceuticals I... |
EVP R&D |
• – – |
2019-05-20 |
4 |
D |
$28.69 |
$95,279 |
D/D |
(3,321) |
101,656 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
EVP R&D |
• – – |
2019-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,438 |
104,977 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
EVP R&D |
• – – |
2019-03-04 |
4 |
D |
$33.41 |
$215,361 |
D/D |
(6,446) |
98,539 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
EVP R&D |
• – – |
2019-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
104,985 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
EVP R&D |
• – – |
2019-01-15 |
4 |
D |
$24.25 |
$17,339 |
D/D |
(715) |
100,485 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
EVP R&D |
• – – |
2019-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750 |
101,200 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Interim Co-President & EVP R&D |
• – – |
2018-09-04 |
4 |
D |
$29.18 |
$259,203 |
D/D |
(8,884) |
101,200 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Interim Co-President & EVP R&D |
• – – |
2018-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
110,084 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Interim Co-President & EVP R&D |
• – – |
2018-08-23 |
4 |
D |
$26.05 |
$212,855 |
D/D |
(8,171) |
110,084 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Interim Co-President & EVP R&D |
• – – |
2018-07-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,500 |
118,255 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2018-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,687 |
119,902 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2018-05-22 |
4 |
D |
$40.82 |
$67,231 |
D/D |
(1,647) |
118,255 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2018-03-12 |
4 |
OE |
$8.50 |
$42,917 |
D/D |
5,049 |
5,049 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2018-03-02 |
4 |
D |
$32.53 |
$147,361 |
D/D |
(4,530) |
22,499 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-09-28 |
4 |
OE |
$7.00 |
$157,073 |
D/D |
21,000 |
14,285 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-08-16 |
4 |
D |
$54.86 |
$145,050 |
D/D |
(2,644) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-07-18 |
4 |
OE |
$8.50 |
$85,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-07-18 |
4 |
AS |
$65.00 |
$650,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-06-26 |
4 |
AS |
$55.47 |
$3,472,955 |
D/D |
(60,000) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-06-26 |
4 |
OE |
$8.50 |
$510,000 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2017-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2016-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Executive Vice President |
• – – |
2016-03-02 |
4 |
D |
$31.75 |
$40,354 |
D/D |
(1,271) |
8,729 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
